DSIP (10mg)

Delta Sleep-Inducing Neuropeptide Research Compound

DSIP (10mg) will be supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide first isolated in 1974 from the cerebral venous blood of rabbits induced into slow-wave (delta) sleep. It is studied for sleep regulation, stress response, and neuroendocrine modulation. Distinct from sedative pharmaceuticals, DSIP is studied for promoting natural sleep architecture — specifically the deep delta-wave sleep stages associated with recovery and hormonal regulation.

DSIP levels fluctuate with the sleep-wake cycle and decline with chronic stress, making it a research focus in the sleep–cortisol–recovery relationship.

Key Research Areas

• Sleep Architecture — Studied for delta-wave sleep promotion without sedation or dependence
• Cortisol Regulation — Associated with reduced cortisol and ACTH levels in stress models
• HPA Axis — Studied for HPA-axis and stress response modulation
• Sleep-Linked GH Release — Studied in connection with nocturnal GH release and recovery cascades
• Neuroprotection & Antioxidant — Emerging research on cellular antioxidant properties

Supplied as lyophilized powder at 99.002% purity as reported on the CoA, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.